Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma That Has Not Responded to Previous Treatment
Clinical trial NCT00022438 · COMPLETED
Trial details
- NCT number
- NCT00022438
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-06-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.